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Abstract 
In healthy adults, the ability to prioritize learning of highly valued information is supported by 
executive functions, and enhances subsequent memory retrieval for this information. In 
Alzheimer’s disease (AD) and behavioural-variant frontotemporal dementia (bvFTD), marked 
deficits are evident in learning and memory, presenting in the context of executive dysfunction. 
It is unclear if these patients show a typical memory bias for higher valued stimuli. We 
administered a value-directed word-list learning task to AD (n=10) and bvFTD (n=21) patients 
and age-matched healthy controls (n=22). Each word was assigned a low, medium or high point 
value and participants were instructed to maximize the number of points earned across three 
learning trials. Participants’ memory for the words was assessed on a delayed recall trial, 
followed by a recognition test for the words and corresponding point values. Relative to 
controls, both patient groups showed poorer overall learning, delayed recall and recognition. 
Despite these impairments, AD patients preferentially recalled high-value words on learning 
trials, and showed significant value-directed enhancement of recognition memory for the words 
and points. Conversely, bvFTD patients did not prioritize recall of high-value words during 
learning trials, and this reduced selectivity was related to inhibitory dysfunction. Nonetheless, 
bvFTD patients showed value-directed enhancement of recognition memory for the point 
values, suggesting a mismatch between memory of high-value information and the ability to 
apply this in a motivationally salient context. Our findings demonstrate that value-directed 
enhancement of memory may persist to some degree in patients with dementia, despite 
pronounced deficits in learning and memory. 
 
Keywords: Alzheimer’s disease; frontotemporal dementia; memory; executive function; 
reward  
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Introduction 
Every day, we encounter enormous amounts of information, which vary in terms of relative 
value or importance. The ability to prioritise what we need to learn and remember for higher 
valued information is therefore critical for maximizing memory efficiency. Indeed, evidence 
suggests that reward value plays a key role in shaping episodic memory (Shohamy & Adcock, 
2010). The cognitive mechanisms by which this effect is achieved, however, remain unclear. 
 
Encoding selectivity has been examined in healthy adults using the value-directed 
remembering (VDR) paradigm (Castel, Benjamin, Craik, & Watkins, 2002), where participants 
are presented with lists of words, which are each assigned a point value to signify its relative 
importance. A consistent finding in studies of both young and older healthy adults is that the 
probability of immediate (short-term) word recall increases with point value (Castel et al., 
2002; Castel, Farb, & Craik, 2007). Importantly, age-related differences in recall are observed 
for words with lower values but not those with higher values, indicating that the ability to 
prioritise memory for highly valued information persists with healthy aging, despite declines 
in memory for less valued information (Castel et al., 2002). Furthermore, higher selectivity in 
encoding is associated with greater working memory capacity (Castel, Balota, & McCabe, 
2009; Hayes, Kelly, & Smith, 2013) and enhances subsequent recognition memory for the 
words and associated point values, such that higher valued words are more accurately retrieved 
(Castel et al., 2007; McDonough, Bui, Friedman, & Castel, 2015).  
 
Value-directed remembering therefore has interventional potential in neurodegenerative 
syndromes in which marked episodic memory deficits are present. Behavioural-variant 
frontotemporal dementia (bvFTD) and Alzheimer’s disease (AD) are two such syndromes in 
which episodic memory impairments are well-established, but have been proposed to be driven 
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by different neurocognitive mechanisms. Owing to the predominantly prefrontal burden of 
neuropathology and prominent executive dysfunction in bvFTD (Kipps, Hodges, Fryer, & 
Nestor, 2009; Kramer et al., 2005), it has been suggested that deficits in strategic encoding and 
retrieval mechanisms underlie episodic memory impairment in these patients (Pasquier, 
Grymonprez, & Lebert, 2001; Wicklund, Johnson, Rademaker, Weitner, & Weintraub, 2006). 
However, both prefrontal and medial temporal lobe regions have been implicated in episodic 
memory dysfunction in bvFTD (Irish, Piguet, Hodges, & Hornberger, 2014; Pennington, 
Hodges, & Hornberger, 2011). Conversely, episodic memory deficits in AD are considered to 
reflect deficits in memory encoding, storage and consolidation (Golby et al., 2005; Lekeu et 
al., 2010), attributable to atrophy predominantly in the medial temporal lobes and 
posteromedial cortices (Irish et al., 2016; Ranganath & Ritchey, 2012). Concomitant deficits 
in executive function, however, are also commonly reported in AD (Swanberg, Tractenberg, 
Mohs, Thal, & Cummings, 2004), particularly with progression of the disease (Ramanan et al., 
2016). Nevertheless, the degree to which executive deficits differentially contribute to episodic 
memory dysfunction in bvFTD and AD remains largely underexplored.  
 
To our knowledge, only one study has investigated value-directed memory selectivity in AD 
(Castel et al., 2009). Using the VDR paradigm, Castel et al. (2009) found that AD patients 
showed better immediate recall of high-value compared to low-value words. On the other hand, 
value-directed memory selectivity has not been investigated in bvFTD. Importantly, AD and 
bvFTD patients show similar impairments in working memory and cognitive flexibility 
(Giovagnoli, Erbetta, Reati, & Bugiani, 2008). In contrast, bvFTD patients show 
disproportionate impairments in inhibitory control and value-based decision-making, which 
are associated with degenerative changes in the ventromedial prefrontal cortex and striatum 
(Hornberger et al., 2010; Kloeters, Bertoux, O'Callaghan, Hodges, & Hornberger, 2013; 
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O'Callaghan, Naismith, Hodges, Lewis, & Hornberger, 2013). Nonetheless, it remains to be 
explored whether deficits in inhibitory control and value-based processing can impact on 
learning and memory. Of primary interest is whether value-directed memory selectivity is 
comparably affected across AD and bvFTD, and the underlying cognitive mechanisms driving 
any such deficits. 
 
In addition to examining how memory selectivity is affected in AD and bvFTD, we were also 
interested in investigating the impact of value-directed encoding on subsequent memory 
retrieval. While healthy older adults show enhanced memory for rewarding stimuli (Castel, 
Balota, & McCabe, 2008; Spaniol, Schain, & Bowen, 2014), it is unclear  whether reward value 
is sufficient to ameliorate memory impairments in neurodegenerative conditions. Whether a 
value-directed memory enhancement effect persists in patients with dementia is of clinical 
relevance, given the potential therapeutic implications in supporting memory for information 
that holds greater relative value.   
 
The first aim of this study was to assess strategic value-directed encoding in AD and bvFTD 
using a simplified version of the VDR paradigm, where the same word-list is presented over 
three immediate recall learning trials, followed by a delayed recall trial and recognition test. 
Considering the widespread executive dysfunction and deficits in value-based decision making 
in bvFTD, we hypothesized that value would have no effect on immediate recall in bvFTD. In 
contrast, AD patients may learn to prioritise recall of higher valued words over repeated trials, 
in keeping with previous reports of greater recall of high-value versus low-value words in this 
patient group. Secondly, we aimed to examine the relationship between encoding selectivity 
and profiles of executive dysfunction, to investigate whether deficits in working memory, 
cognitive flexibility and inhibition differentially associate with selectivity in AD and bvFTD. 
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The final aim of this study was to explore whether reward value would enhance memory for 
the words and associated point values following a time delay. We hypothesised that value-
directed enhancement of memory would be evident in AD, but attenuated in bvFTD patients, 
in-line with their expected performance on the preceding immediate recall trials. 
 
Material and methods 
Participants 
Thirty-one dementia patients (bvFTD=21; AD=10) and 22 age-matched healthy controls were 
recruited. All bvFTD patients fulfilled clinical diagnostic criteria for probable bvFTD 
(Rascovsky et al., 2011), with insidious onset, progressive decline in social behaviour and 
personal conduct, apathy, emotional blunting and loss of insight and presence of frontal atrophy 
on brain imaging. All AD patients met clinical diagnostic criteria for probable AD (McKhann 
et al., 2011), with worsening episodic memory impairment in the context of preserved 
personality and behaviour and evidence of medial temporal lobe atrophy on imaging. Disease 
duration was estimated as the number of years elapsed since the reported onset of symptoms. 
The Frontotemporal Dementia Rating Scale (FRS; Mioshi, Hsieh, Savage, Hornberger, & 
Hodges, 2010) and Clinical Dementia Rating Scale (CDR; Morris, 1997) were used to 
determine disease severity in bvFTD and AD patients. All participants underwent general 
cognitive screening using the Addenbrooke’s Cognitive Examination-III (ACE-III; Hsieh, 
Schubert, Hoon, Mioshi, & Hodges, 2013) to determine their overall level of cognitive 
functioning. Age-matched healthy controls were recruited from a research volunteer panel and 
scored >88 on the ACE-III (Hsieh et al., 2013). 
Exclusion criteria for all participants included current or prior history of mental illness, 
significant head injury, movement disorders, cerebrovascular disease (stroke, transient 
ischaemic attacks), alcohol or other drug abuse and limited English proficiency. 
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Ethics statement 
All participants provided written informed consent and this study was conducted in accordance 
with the Declaration of Helsinki. Ethical approval was obtained from local Human Research 
Ethics Committees. 
 
Assessment of executive function and verbal episodic memory 
Assessment of executive function included measures of working memory (Digit Span 
Backward (DSB); total score; Wechsler, 1997), cognitive flexibility (Trail Making Test; B-A 
time; Reitan & Wolfson, 1985) and verbal inhibition (Hayling Sentence Completion Test; AB 
error score; Burgess & Shallice, 1997). Further details of the executive function tests are 
detailed in Appendix A. 
 
All participants underwent comprehensive neuropsychological assessment of verbal episodic 
memory in terms of immediate recall, delayed recall, and delayed recognition using the Rey 
Auditory Verbal Learning Test (RAVLT; Rey, 1941). Further details are provided in Appendix 
A.  
 
Value-directed memory task 
The value-directed memory (VDM) task was adapted from previous studies (Castel et al., 2008; 
2009). The current version assessed learning, recall and recognition of a list of 12 words, where 
each word was assigned a value of 1, 5 or 10 points. 
 
Stimuli and materials 
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The stimuli consisted of two lists of 12 words. Words from List 1 were presented during 
learning, while those in List 2 were presented as novel lures during the recognition memory 
test. Within List 1, 4 words were assigned to each of the low (1 point), medium (5 points) and 
high (10 points) value conditions. All words were concrete nouns containing either 4 or 5 
letters. Words assigned to each condition were matched in terms of word frequency, familiarity, 
concreteness and imageability, determined using the MRC Psycholinguistic Database 
(http://www.psych.rl.ac.uk). Lists and words assigned per task phase and condition were 
counterbalanced across participants. 
 
The VDM task was programmed using E-Prime 2.0 software (Psychology Software Tools, 
Pittsburgh, PA), and testing was conducted on a laptop with a 14-inch LED-backlit display. 
Participants responded verbally on the immediate recall learning trials, delayed recall trial and 
recognition tests.  
 
Procedure 
Following presentation of instructions, participants were presented with examples of the word 
and point stimuli. This included presentation of 3 words (worth 1, 5 and 10 points), followed 
by an immediate recall trial. After participants recalled the example words, feedback was 
provided regarding the total number of points earned and how this number was calculated. 
Participants were told that the aim of the task was to gain as many points as possible. 
Participants’ understanding of the task instructions was checked before commencing the 
experimental task. Procedures for the learning and test phases are illustrated in Figure 1. 
 
Learning phase 
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On each learning trial, participants viewed a list of 12 words, displayed one at a time on the 
computer screen. The order of presentation was randomised, with no more than 2 words from 
the same condition appearing consecutively. Each word was displayed for 2000 ms before the 
associated point value appeared below the word for an additional 2000 ms. Following 
presentation of the word list, participants were asked to recall as many words as possible from 
the list. Participants then received feedback regarding their total point score and were 
encouraged to beat their previous score on each upcoming trial. This procedure was repeated 
for trials 2 and 3 of the learning phase. To limit list-order effects, word-list presentation was 
randomised on each trial. 
 
Following the learning phase, participants were asked to describe their encoding strategy 
throughout the 3 trials of the learning phase. Based on their responses, strategies were 
categorised as Type 1) ‘focusing more on high-value words’ or 2) ‘ignoring value’. 
 
Test phase 
Delayed recall 
A surprise recall test was administered following a 20-minute delay, during which participants 
completed a reading comprehension task for a separate study. On the delayed recall test, 
participants were asked to recall as many words as possible from the learning phase. 
Participants did not have a time limit for recall. No feedback was provided regarding the 
number of points earned. 
 
Word and points recognition 
Immediately after the delayed recall trial, recognition memory for the words and associated 
point values was assessed. The recognition phase consisted of 24 trials, where all 12 of the 
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words from the learning phase were individually displayed, intermixed with the 12 novel lure 
words. On each trial, participants first made a word recognition decision by judging whether 
they had seen the word during the learning phase (yes/no) or whether they didn’t know (“don’t 
know”). The prompt “Yes | No | Don’t know” was written below the word. Following each 
“yes” response, participants made a point recognition decision by responding whether that 
word had been worth 1, 5 or 10 points. The prompt “1 | 5 | 10 | Don’t know” was displayed 
below the word. The point recognition question was not asked following “no” or “don’t know” 
responses on the word recognition question. The “don’t know” response option was offered in 
order to reduce potential contamination of guessing, in accordance with previously reported 
procedures (Leshikar & Duarte, 2013; Wong et al., 2017). Recognition trials were self-paced 
and presented in a random order. No feedback was provided regarding response accuracy. 
 
Outcome measures 
Learning phase 
Outcome measures from the 3 immediate recall learning trials were the number of words 
recalled in each value condition. Participants’ self-reported encoding strategies were also 
included as a categorical outcome measure. Finally, to examine value-directed strategic 
encoding ability, a selectivity index was calculated using the following equation:  
𝑆𝑒𝑙𝑒𝑐𝑡𝑖𝑣𝑖𝑡𝑦 𝑖𝑛𝑑𝑒𝑥 (𝑆𝐼)
=
[ 𝑇𝑜𝑡𝑎𝑙 𝑝𝑜𝑖𝑛𝑡𝑠 𝑒𝑎𝑟𝑛𝑒𝑑 + (𝑐ℎ𝑎𝑛𝑐𝑒 𝑠𝑐𝑜𝑟𝑒  𝑡𝑜𝑡𝑎𝑙 𝑤𝑜𝑟𝑑𝑠 𝑟𝑒𝑐𝑎𝑙𝑙𝑒𝑑)]
[𝐼𝑑𝑒𝑎𝑙 𝑝𝑜𝑖𝑛𝑡𝑠 𝑒𝑎𝑟𝑛𝑒𝑑 + (𝑐ℎ𝑎𝑛𝑐𝑒 𝑠𝑐𝑜𝑟𝑒  𝑡𝑜𝑡𝑎𝑙 𝑤𝑜𝑟𝑑𝑠 𝑟𝑒𝑐𝑎𝑙𝑙𝑒𝑑)]
 
As previously described (Ariel & Castel, 2013; Cohen, Rissman, Suthana, Castel, & Knowlton, 
2016), the SI is a measure of a participant’s point score, after taking into account the ideal point 
score and the chance point scores, which is weighted by the number of words recalled. The 
ideal point score is the maximum number of points that can be earned for recalling n number 
of words (e.g. the ideal point score for recalling 4 words is 10 + 10 + 10 + 10 = 40). The chance 
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score represents the average points earned, and is calculated as the mean point value of the 12 
words on each learning trial (i.e. 5.33). In line with previously reported procedures (Cohen et 
al., 2016), the weighting procedure was employed to account for low overall word recall 
performance in AD and bvFTD patients. SI scores range from 0 to 1, with values close to 1 
indicating greater selectivity for high-value words. The trial 3 SI score was included in our 
analyses as a measure of participants’ ability to develop value-directed strategic encoding by 
the end of the learning phase.  
 
Test phase 
Delayed recall 
The number of words recalled on each value condition was included as the outcome measure 
on the delayed recall trial. 
 
Word recognition 
Word recognition responses were classified as ‘studied word hit’ (correct recognition), ‘studied 
word miss’ (incorrect rejection) and ‘studied DK (don’t know)’ for words previously seen 
during the learning phase; and ‘unstudied word hit’ (correct rejection), ‘unstudied word miss’ 
(false alarm) and ‘unstudied DK’ for novel words presented in the test phase only. As the points 
recognition question was asked following each ‘yes’ response to the word recognition question, 
regardless of whether the response was a correct recognition or false alarm, the point value 
subsequently ascribed to each false alarm was used to classify the response as a low-, medium- 
or high-value false alarmnot analysed. To correct for false alarms per condition, corrected word 
recognition was calculated by subtracting the percentagenumber of false alarms (number of 
false alarms / 12  100) in each condition from the number percentage of correct recognition 
responses in each condition (e.g. number of correct recognition low-value / 4  100).  
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Points recognition 
Points recognition responses were classified as ‘points-recollected’ (i.e. points-correct) or 
‘points-unrecollected’ (i.e. ‘points-incorrect’ or ‘points-don’t know’). Given that the points 
recognition question was not asked following "no” or “don’t know” word recognition 
responses, points recognition for such words were classified as ‘points-unrecollected’. 
Following previously reported procedures (Rosa, Deason, Budson, & Gutchess, 2014), points 
recognition accuracy was calculated by taking the percentage of points-correct responses out 
of the total number of words in each condition (e.g. percentage points-correct low-value = (points-
correct low-value / 4)  100).  
 
Statistical analyses 
Data were analysed using SPSS 20.0 (SPSS Inc., Chicago, ILL., USA). Normally distributed 
variables, as determined by Shapiro-Wilks tests, were compared across groups using ANOVAs 
followed by Tukey post hoc tests. Data that were not normally distributed were analysed using 
Kruskal-Wallis tests followed by post hoc pairwise comparisons, using Dunn’s (1964) 
procedure with a Bonferroni correction for multiple comparisons. A chi-squared test was used 
to compare sex distribution across groups.  
 
For each recall trial (Trials 1–3 immediate recall, delayed recall), a group (3)  condition (3) 
repeated measures ANOVAs was conducted to contrast the number of words recalled per 
condition across groups. Similarly, group (3)  condition (3) repeated measures ANOVAs were 
conducted to contrast corrected word and points recognition across conditions and groups. Post 
hoc simple-effects tests were conducted to examine differences between conditions within each 
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participant group. All pairwise comparisons of the main effects and simple effects were 
adjusted for multiple comparisons using the Sidak method.  
 
Due to the small numbers of participants reporting certain strategy types, Fisher’s exact test 
was used to compare the distribution of participants’ self-reported encoding strategies across 
groups. Independent samples t-tests were used to determine whether Trial 3 SI scores, delayed 
recall, word recognition or points recognition differed according to self-reported encoding 
strategy use. 
 
Within each group, Spearman rank correlations were used to examine relationships between 
encoding selectivity on Trial 3 of the VDM task (SI scores) and background 
neuropsychological measures of executive function (DSB total, TMT B  A time and Hayling 
AB error score) and verbal episodic memory encoding (RAVLT learning trial 5 recall). A one-
tailed significance level, corrected for multiple comparisons at of p<.01 was applied for all 
correlational analyses. 
 
Results 
Demographics 
Demographics and clinical characteristics are detailed in Table 1. Shapiro-Wilk tests indicated 
that age, total years of education, disease severity (CDR SoB) and functional impairment (FRS) 
data were normally distributed, whereas measures of disease duration and general cognition 
(ACE-III) showed non-normal distributions. Participant groups were matched for age (p=.091) 
and sex distribution (p=.363). An overall group difference was evident for total years of 
education (p=.007), with controls being more educated than bvFTD patients (p=.005). Total 
years of education did not differ between the two patient groups (p=.558) or between AD 
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patients and controls (p=.264). Importantly, the patient groups were matched for disease 
duration (p=.751) and disease severity (CDR SoB; p=.991). The bvFTD patients showed a 
trend towards higher levels of functional impairment relative to AD patients (FRS; p=.066). 
While both patient groups were significantly impaired relative to controls (all p values <.001) 
on the ACE-III cognitive screening measure, performance was comparable for bvFTD and AD 
patients (p=.353).  
 
Assessment of executive function and verbal episodic memory 
Background executive function and verbal episodic memory variables showing normal 
distributions included RAVLT learning trials 2 and 3, with the remaining variables showing 
non-normal distributions. Patient groups displayed characteristic profiles of executive 
dysfunction relative to controls on tests of working memory (DSB; p values <.001), cognitive 
flexibility (TMT B  A time; p values <.001) and verbal inhibition (Hayling AB error score; p 
values <.014). No significant differences were evident between AD and bvFTD patients on any 
of the executive measures (p values >.47). Encoding, delayed recall and corrected recognition 
performance on the RAVLT are detailed in Table 1. Verbal episodic memory was significantly 
compromised in both patient groups relative to controls across all learning trials (RAVLT 
learning trials 1–5; p values <.001), delayed recall (RAVLT 30-minute recall; p values <.001) 
and corrected recognition (RAVLT corrected recognition; p values <.001). AD and bvFTD 
patients did not differ on any measures of verbal episodic memory performance (p values 
>.110). 
 
 
Value-directed memory task results 
Learning phase 
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Words recalled per condition 
The number of low-, medium- and high-value words recalled per learning trial are illustrated 
in Figure 2A–C. Separate group  condition repeated measures ANOVAs were conducted for 
each learning trial. The group  condition interaction was significant on trials 1, 2 and 3 (Trial 
1: F4,100=4.271, p=.003; Trial 2: F4,100=3.901, p=.006; Trial 3: F4,100=3.819, p=.006), indicating 
that differences in the recall of low-, medium- and high-value words varied across groups. Post 
hoc simple effects tests revealed that controls recalled significantly fewer low-value compared 
to medium-value (p values <.012) and high-value (p values <.001) across trials 1, 2 and 3. 
Furthermore, while controls recalled similar numbers of medium- and high-value words on 
Trials 1 and 3 (p values >.281), they recalled significantly more high-value compared to 
medium-value words on Trial 2 (p=.025). In AD patients, recall of low-, medium- and high-
value words did not differ on trials 1 or 2. On trial 3 however, AD patients recalled significantly 
more high-value compared to low-value words (p=.023) and showed a trend towards recalling 
more medium-value compared to low-value words (p=.06). In contrast, bvFTD patients did not 
show any value-directed prioritisation of word recall, with similar numbers of low-, medium- 
and high-value words recalled across the 3 learning trials (p values >.159).  
 
In addition, analyses for Trial 1, 2 and 3 each revealed significant main effects of group (Trial 
1: F2,50=26.091, p<.001; Trial 2: F2,50=36.801, p<.001; Trial 3: F2,50=43.393, p<.001), with 
controls outperforming AD (p<.001) and bvFTD (p<.001) patients. No significant group 
differences were evident when comparing AD and bvFTD patients on each of the learning trials 
(Trial 1: p=.399; Trial 2: p=.109; Trial 3: p=.091). Significant condition effects were also 
observed on each learning trial (Trial 1: F2,100=15.214, p<.001; Trial 2: F2,100=6.241, p=.003; 
Trial 3: F2,100=14.452, p<.001), reflecting the greater number of high-value versus low-value 
words recalled (p values <.004). Across all groups, more medium-value versus low-value 
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words were recalled on Trials 1 and 3 (p<.001) but not Trial 2 (p=.107). Recall of medium- 
and high-value words did not differ on any of the learning trials, averaged across all groups (p 
values >.311). Overall, results from the immediate recall learning trials indicate that controls 
showed a robust value-directed enhancement effect on encoding across all 3 trials. Whereas 
AD patients were able develop a value-directed encoding strategy by the 3rd learning trial, 
bvFTD patients did not appear to prioritise recall of higher value words across trials. 
 
Self-reported encoding strategy 
Participants’ self-reported encoding strategies were categorised as 1) focusing more on high-
value words or; 2) did not focus on the value of the words. Results from Fisher’s exact test 
revealed that the distribution of encoding strategies was significantly different across groups 
(p=.004). The most commonly reported strategy in controls (86.4%) and AD patients (60%) 
was ‘focusing more on high-value words’. In contrast, responses from bvFTD patients 
indicated that they had not implemented any specific encoding strategy, and when prompted 
with the two strategy types, the majority (61.9%) reported that they ‘did not focus on the value 
of the words’. 
 
Within AD patients, those who reported ‘focusing more on high-value words’ had significantly 
higher Trial 3 SI scores compared to those who ‘did not focus on the value of the words’ 
(t8=3.375, p=.01). In contrast, Trial 3 SI scores did not differ according to self-reported 
encoding strategy use in bvFTD patients (t19=0.432, p=.671). In other words, self-reported 
encoding selectivity did not appear to be related to actual encoding selectivity in bvFTD. 
Performance on subsequent word recall, word recognition and points recognition measures did 
not differ between these strategy-based subgroups in AD or bvFTD (p values >.05). 
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Selectivity index from immediate recall learning Trial 3 
SI scores from the 3rd immediate recall learning trial provide a measure of value-directed 
strategic encoding ability at the end of the learning phase. Mean Trial 3 SI scores in both AD 
(M=.81; SD=.13, p=.014) and bvFTD (M=.74, SD=.23, p<.001) were significantly lower than 
controls (M=.94, SD=.12), though the two patient groups did not differ (p=1.0). Analyses of SI 
scores across all 3 immediate recall learning trials are included in Appendix C. 
 
Relationships between Trial 3 selectivity index, executive function and episodic memory  
The ability to prioritise recall of high-value words by Trial 3 of the VDM task learning phase 
differentially associated with executive function across patient groups (see Table 2). In bvFTD, 
higher selectivity on Trial 3 was significantly associated with better performance on measures 
of verbal inhibition (r=.560, p=.01). Weak associations between Trial 3 selectivity and 
working memory (DSB: r=.384, p=.044) and cognitive flexibility (r=.416, p=.048) were also 
identified, but these did not reach significance after correcting for multiple comparisons. In 
contrast, no significant associations were identified between Trial 3 SI scores and performance 
on tests of executive function in AD patients (all p values >.119) or controls (all p values 
>.267). Furthermore, selectivity on Trial 3 of the VDM task was not significantly associated 
with verbal episodic memory encoding performance on the final learning trial of the RAVLT 
in any of the participant groups (p values >.104). Altogether, results from our correlational 
analyses indicate a specific association between value-directed strategic encoding and 
inhibitory dysfunction in bvFTD patients only. Conversely, correlational analyses within each 
group revealed that encoding selectivity on the final learning trial is not related to verbal 
episodic learning capacity, as indexed on the final learning trial of a separate word-list learning 
task (RAVLT Trial 5 total words recalled; all p values>.103) 
 
 17 
Test phase 
Delayed recall 
The number of low-, medium- and high-value words recalled on the delayed recall trial are 
shown in Figure 2D. Results from a repeated measures ANOVA revealed a trend towards a 
significant group  condition interaction (F4,100=2.456, p=.051), suggesting that the condition 
effect varied across groups. Post hoc simple effects tests indicated that controls recalled 
significantly more high- and medium-value compared to low-value words (p values <.006), 
whereas recall of medium- and high-value words did not differ significantly (p=.959). In 
contrast, no such value-directed enhancement effect was observed in the delayed recall of low-
, medium- and high-value words in AD (p values >.688) or bvFTD (p values <.199) patients. 
There was also a significant main effect of group (F2,50=30.172, p<.001), where controls 
outperformed both AD (p<.001) and bvFTD (p<.001) patients. The overall effect of condition 
was not significant (F2,100=2.706, p=.072). Overall, our results indicate that a value-directed 
enhancement effect on delayed recall memory was evident in controls but not AD or bvFTD 
patients. Analyses of the total number of words recalled and points earned on the delayed recall 
trial, regardless of condition, are included in Appendix B. 
 
Word recognition 
Figure 3A depicts corrected word recognition accuracy (hits – false alarms) for each condition 
across AD, bvFTD and controls. A group (3) by condition (3) repeated measures ANOVA 
revealed a significant group effect for corrected word recognition accuracy (F2,50=12.668, 
p<.001). This group effect was driven by significantly lower corrected word recognition 
accuracy in both AD (p<.001) and bvFTD (p<.001) patients relative to controls, though the 
two patient groups did not differ (p=.841). The main effect of condition was not significant 
(F2,100=7.7732.194, p=.001117), with greater corrected recognition accuracy in the low-value 
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compared to high-value condition (p=.001), a trend towards greater accuracy in the low-value 
compared to medium-value condition (p=.062) and no significant difference between the 
medium- and high-value conditions (p=.449). Tand there was no significant interaction 
between group and condition (F4,100=0.446861, p=.77549). Post hoc simple effects tests 
revealed that within the control and bvFTD groups, each group, corrected word recognition 
accuracy did not differ between conditions (all p values >.253controls: low- vs. medium-value 
p=.377; low- vs. high-value p=.174; medium- vs. high-value p=.993; bvFTD: low- vs. medium-
value p=.635, low- vs. high-value p=.094, medium- vs. high-value p=.707). In contrast, AD 
patients showed significantly greater word recognition hits in the high-value compared to low-
value condition (p=.02), with no significant difference between the medium- and low-value 
conditions (p=.328) or the high- and medium-value conditions(p=.651). Thus, overall corrected 
word recognition accuracy was similar across conditions in controls and bvFTD patients, 
whereas AD patients showed significant value-directed enhancement of memory for high-
value compared to low-value words. reduced in AD and bvFTD relative to controls, but did 
not appear to vary across the low-, medium- and high-value conditions. Analyses of 
uncorrected word recognition hits and false alarms are included in Appendix D.  
 
Points recognition 
Figure 3B depicts points recognition accuracy for each condition across AD, bvFTD and 
controls. An overall group effect on points recognition accuracy was evident (F2,50=14.96, 
p=<.001), driven by significantly lower accuracy in both AD (p<.001) and bvFTD (p<.001) 
compared to controls. There was also a significant main effect of condition (F2,100=11.317, 
p<.001), where high-value words were recognised more accurately than low- (p<.001) and 
medium-value (p=.002) words. No significant difference was observed between low- and 
medium-value words (p=.613). The interaction between group and condition was not 
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significant (F4,100=1.438, p=.227). However, post hoc simple effects tests revealed that within 
controls, points recognition was significantly higher in the high-value compared to medium-
value conditions (p=.012), with no significant differences between low- and medium-value 
(p=.377) or low- and high-value (p=.363) conditions. Conversely, only the difference between 
low- and high-value conditions was significant in AD (p=.03) and bvFTD (p=.016) patients. 
As such, both patient groups showed significant value-directed enhancement of memory for 
the points associated with high-value compared to low-value words, whereas this effect was 
most pronounced between high- and medium-value words in controls. Additional analyses 
exploring potential response biases on points recognition are included in Appendix E. 
 
Discussion 
This is the first study to investigate preferential learning and retention of novel information 
that varies according to allocated value in two neurodegenerative syndromes. Our results in 
AD suggest that value-directed learning may support subsequent recognition memory for high-
value information, despite showing no benefit for delayed free recall performance. In contrast, 
bvFTD patients did not preferentially recall high-value information during the learning phase, 
and this appeared to be associated with inhibitory dysfunction. Here, we discuss the 
implications of our findings in terms of in the underlying cognitive mechanisms that contribute 
to value-directed learning and memory in these patient groups.  
 
Value-directed learning 
In AD, word-list learning was influenced by the value assigned to each word. With the 
opportunity to strategically encode high-value words across three immediate recall learning 
trials, AD patients learned to preferentially recall more high-value relative to low-value words. 
This is consistent with previous findings in AD (Castel et al., 2009). Importantly, when asked 
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about their encoding strategy, the majority of AD patients reported having focused more on 
high-value words. Furthermore, those who reported prioritising encoding of high-value words 
showed higher selectivity on the final learning trial. Our findings in AD therefore demonstrate 
a relatively preserved capacity for value-directed learning over repeated trials, despite an 
overall reduction in the total number of words recalled. 
 
In contrast, no clear evidence of preferential learning according to value was observed in 
bvFTD patients, where the number of low-, medium- and high-value words did not differ across 
trials. While this appeared to be corroborated by the encoding strategies reported by bvFTD 
patients––the majority of whom reported ignoring the value of the words––it is important to 
note that there was no clear relationship between self-reported selectivity and actual selectivity 
as indexed on the final learning trial. This mismatch may be related to loss of insight, which is 
frequently reported in bvFTD (Banks & Weintraub, 2009; Hornberger et al., 2014). 
Nonetheless, our novel finding of impaired strategic value-directed learning in bvFTD align 
with previous findings which suggest that strategic encoding deficits impact on episodic 
memory impairment in bvFTD (Glosser, Gallo, Clark, & Grossman, 2002). Our findings 
therefore build upon research which indicates that memory impairment in bvFTD may be 
driven by deficits in strategic organisational processes at the encoding level (Pasquier et al., 
2001; Wicklund et al., 2006). Nonetheless, while value-directed selectivity appeared to be 
limited in bvFTD, future studies may benefit from additional indices of strategic organisation 
during encoding. For example, analyses of serial order or item effects may provide further 
insights regarding recall performance during learning trials, and determine whether bvFTD 
patients show deficits in their capacity to recall high-value items first, to group together the 
four high-value items or to recall new words across trials. 
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Associations between value-directed selectivity and executive function 
The second aim of this study was to examine the extent to which value-directed selectivity is 
associated with executive functions, including working memory, cognitive flexibility and 
verbal inhibition. The selectivity score was included as a measure of memory efficiency on the 
final learning trial, with higher scores indicating a bias towards recalling high-value words. 
Within bvFTD patients, lower selectivity on the final learning trial was strongly associated 
with poorer verbal inhibition. Inhibitory dysfunction is commonly reported in bvFTD (Bozeat, 
Gregory, Ralph, & Hodges, 2000; Hornberger, Piguet, Kipps, & Hodges, 2008; Krueger et al., 
2009), and is associated with prefrontal cortex atrophy, particularly in the ventromedial regions 
(Hornberger, Geng, & Hodges, 2011; O'Callaghan et al., 2013). Atrophy in this region has also 
been associated with impaired episodic memory recall performance in bvFTD, though the 
mechanisms through which ventromedial prefrontal cortex functions impact on episodic 
memory remain to be established (Wong, Flanagan, Savage, Hodges, & Hornberger, 2014). Of 
relevance, studies of directed forgetting––where stimuli are presented with instructions to 
either ‘remember’ or ‘forget’––also highlight the importance of prefrontally-mediated 
inhibitory functions for selective forgetting of ‘to-be-forgotten’ versus ‘to-be-remembered’ 
information (Anderson & Hanslmayr, 2014; Wylie, Foxe, & Taylor, 2008). In the same vein, 
the significant association between inhibitory function and value-directed selectivity in our 
study suggests that bvFTD patients may have difficulty selectively inhibiting the encoding of 
low-value words, in order to prioritize encoding of the high-value words. 
 
In contrast, value-directed selectivity did not correlate with executive function in AD. While it 
is possible that selectivity is related to other executive functions that are not captured on our 
tests, previous reports indicate that this is not significantly associated with working memory 
capacity in AD (Castel et al., 2009). Nonetheless, the adaptations made to reduce task 
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complexity in our study (e.g., repeated learning trials using the same stimuli) may have 
restricted the range of selectivity scores on Trial 3. Consistent with their improvements across 
learning trials in terms of preferential recall of high-value words, AD patients also showed 
improvement in value-directed selectivity across the learning trials (see Appendix C). Related 
to this point, encoding selectivity in our control group also appeared to be unrelated to 
performance on executive measures, though this was likely due to ceiling effects. Finally, it is 
important to note that across all participant groups, encoding selectivity on the value-directed 
learning task was not associated with general episodic encoding capacity per se. Taken 
together, whereas our findings in bvFTD demonstrate a clear link between reduced value-
directed selectivity and inhibitory dysfunction, similar associations were not evident in AD 
patients or controls, nor were there any associations between selectivity and encoding capacity. 
 
Value-directed enhancement of episodic memory recall and recognition 
The final aim of this study was to examine the impact of value-directed learning on measures 
of delayed recall, as well as recognition for the words and associated point values. Given the 
extremely low delayed recall performance in AD, it is difficult to draw conclusions regarding 
any differential effects of value-directed encoding on subsequent memory recall. While bvFTD 
patients recalled fewer overall words at on the delayed recall relative to learning trials, no clear 
effect of value was evident. Our results on the delayed free recall trial therefore indicate that 
value was not sufficient to reduce the significant episodic memory recall deficits in either AD 
or bvFTD. Conversely, control participants showed a clear value-directed enhancement effect 
on delayed free recall, such that they recalled more medium- and high-value words relative to 
low-value words. While previous studies have shown this effect on recognition memory (Castel 
et al., 2007), we demonstrate, for the first time, that this enhancement effect also benefits recall 
of higher value information following a short delay in healthy adults. 
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Our corrected word recognition results (i.e. hits – false alarms) did not showed a clear value-
directed enhancement effect in AD patients any of the groups. Overall, AD patients correctly 
recognised fewer words compared to controls, yet their word recognition performance was 
higher for high-value compared to low-value words. In terms of raw word recognition and false 
positives however, AD patients were more likely to correctly endorse high-value words, and 
tended to attribute more medium point values to false positive word responses (see Appendix 
D). This finding is in line with previous reports of increased susceptibility to false positives 
following value-directed encoding in healthy adults (Bui, Friedman, McDonough, & Castel, 
2013). In contrast, although bvFTD patients endorsed more false positives and also recognised 
fewer words relative to controls, this did not differ across conditions. As such, bvFTD patients 
did not attribute more high compared to medium or low point values to false positive word 
responses. Of note, elevated false positive rates have previously been linked with disinhibition 
in bvFTD patients (Flanagan et al., 2016). Thus, indiscriminate endorsing of items on the 
recognition test may be underpinned by impaired inhibitory function, rather than deficits in the 
capacity to discriminate between previously presented versus novel items. Finally, although 
word recognition did not differ across conditions in controls, this appeared to be due to a ceiling 
effect. Taken together, our results suggest that value was not sufficient to enhance word 
recognition accuracy in bvFTD patients or controls. Conversely, value-directed encoding 
impacts on bothenhanced word recognition performance and false positives in AD only. 
 
On the other hand, both patient groups and controls showed value-directed enhancement of 
memory for the point values associated with each word. Our results in AD demonstrate, for the 
first time, that memory for episodic details , specifically those relating to point value, may be 
supported by value-directed learning. This suggests that memory for highly valued information 
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may persist despite the profound memory impairment in AD, in circumstances where sufficient 
cues are provided to support retrieval. Conversely, although bvFTD patients did not show 
preferential encoding of high-value words during the learning trials, a significant value-
directed enhancement effect on points recognition accuracy was observed. Although this may 
initially seem counterintuitive given that value had no effect on learning performance, our 
results suggest that there may be a disconnection between the encoding and retention of high-
value information and the ability to apply this information in order to maximise points during 
the immediate recall learning trials. While our correlational analyses indicated that reduced 
encoding selectivity was related to inhibitory dysfunction, an additional explanation may be 
that bvFTD patients were not sensitive to the motivational aspect of the reward values during 
the learning task. Indeed, reduced motivation is a diagnostic symptom of bvFTD (Rascovsky 
et al., 2011), and evidence indicates that these patients show altered sensitivity to primary and 
secondary rewards (Fletcher et al., 2015; Perry & Kramer, 2013; Perry, Sturm, Wood, Miller, 
& Kramer, 2015) and poor performance on value-based decision-making tasks (Kloeters et al., 
2013; Strenziok et al., 2011). Conversely, symptoms of apathy are relatively less prevalent in 
AD compared to bvFTD (Chow et al., 2009), and these patient groups show divergent profiles 
of reward sensitivity (Perry et al., 2015). Nonetheless, as we did not include concurrent 
measures of reward sensitivity, whether motivation deficits differentially contribute to value-
directed selective recall performance in bvFTD and AD requires confirmation in future studies.  
 
Collectively, our results demonstrate that AD patients may have the capacity to learn and retain 
information that is associated with a high level of value or importance, providing there is 
adequate repetition when learning and support during retrieval. Importantly, this value-directed 
enhancement of learning and memory was observed despite the significant executive deficits 
present in this patient group. This has clinical implications for the implementation of memory 
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retraining programs in AD, and highlights an important role for motivation in memory. Unlike 
laboratory settings where degrees of importance are clearly assigned, however, in daily life one 
must initially determine the relative value of information encountered, before preferentially 
encoding highly valued information (Castel, McGillivray, & Friedman, 2012). As such, 
supporting the valuation process by emphasizing value or importance may benefit learning and 
memory for certain pieces of information in AD. Further investigations are required, however, 
to establish whether this value-directed enhancement effect persists over longer time delays. 
 
In contrast, although bvFTD patients appear to learn and remember aspects of value-related 
information, they do not appear to apply this knowledge in a motivationally-salient context. As 
such, the provision of clear indicators of value or importance may not be sufficient to overcome 
the significant inhibitory deficits, which impact on preferential recall in these patients. 
Furthermore, encoding selectivity did not appear to be related to episodic memory encoding 
capacity in bvFTD. Additional research is needed in order to disentangle the contributions of 
altered reward sensitivity and inhibitory dysfunction on value-directed selectivity in bvFTD. 
One potential approach would be to contrast performance on a value-directed learning task 
against performance on a selective memory task without any value component, such as the 
item-method directed forgetting paradigm (Anderson & Hanslmayr, 2014). To circumvent the 
problem of impaired insight when eliciting self-reports of encoding strategy, future studies in 
bvFTD may also benefit from incorporating physiological measures of arousal, as evidence 
indicates that healthy adults show greater pupil dilation when studying words associated with 
higher point values (Ariel & Castel, 2013). From a broader clinical perspective, further 
characterisation of the impact of motivation on memory represents an important area of future 
inquiry, especially given the high prevalence of apathy in this patient group (Merrilees et al., 
2013). 
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As discussed above, a potential limitation of our study design is that we did not include 
concurrent measures of sensitivity to value or motivation. Although earning points on the 
experimental task appeared to influence value-directed learning and memory in controls and 
AD patients, it is also possible that point values were insufficient to elicit similarly motivated 
responses in bvFTD. Future studies that incorporate more tangible rewards (e.g. money) may 
further elucidate the impact of different reward types on value-directed learning and memory 
in these patients. Furthermore, the inclusion of additional measures of executive function may 
help further elucidate relationships between value-directed selectivity and different aspects of 
executive function. While neuroimaging analysis was beyond the scope of this study, future 
investigations would benefit from incorporating structural and functional imaging metrics to 
further elucidate the neurocognitive mechanisms underpinning value-directed learning and 
memory in these patient groups. A final issue to note is the relatively small sample size of our 
patient groups. Our findings should therefore be interpreted with this caveat in mind, and future 
examination of value-directed learning and memory in bvFTD and AD will be important for 
confirmation of these novel findings.  
 
Conclusions 
In summary, we have adapted a selective memory task to provide insights into value-directed 
learning and memory in bvFTD and AD patients. In doing so, we have revealed a relatively 
preserved capacity to preferentially learn and recognise high-value information in AD patients. 
While reduced value-directed selectivity was distinctly associated with inhibitory deficits in 
bvFTD, our findings also uncovered a mismatch between memory for rewarding information 
and the ability to apply this knowledge in order to maximise rewards. From a broader 
theoretical viewpoint, our findings provide important insights regarding value-directed 
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memory processes, and highlight the importance of interactions between motivation and 
memory. 
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Figure 1 (A) Example of words and associated points used in the VDM task. (B) Example of 
word presentation procedure during learning phase of the VDM task. (C) Example of word 
and points recognition questions in the test phase of the VDM task. 
 
 
 34 
Figure 2 Number of low-, medium- and high-value words recalled across learning trials (A–C) and on the delayed recall trial (D) of the VDM task. 
Brackets indicate significant post hoc simple effects, *p<.05. 
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Figure 3 (A) Corrected word recognition (hits – false alarms) across conditions and groups 
on the word recognition test. (B) Points recognition accuracy for each condition across groups. 
Error bars represent standard error of the mean. Brackets indicate significant post hoc simple 
effects, *p<.05. 
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Table 1. Demographic and clinical characteristics and performance on neuropsychological measures of executive function and episodic memorya 
  Control AD bvFTD 
Group 
effect 
Control 
vs. bvFTD 
Control 
vs. AD 
bvFTD 
vs. AD 
Sex (M:F) 10:12 6:4 14:7 n.s.    
Age (years) 64.12 (6.82) 67.84 (9.12) 61.50 (7.13) n.s.    
Education (years) 13.81 (2.43) 12.33 (2.86) 11.35 (2.29) ** ** n.s. n.s. 
Disease duration (years)  6.48 (4.99) 5.58 (3.22) n.s.    
CDR SoB [18]  5.28 (1.39) 5.26 (3.22) n.s.    
FRS Rasch score  0.27 (1.14) 0.69 (1.31) #    
ACE-III [100] 96.23 (3.58) 60.80 (12.14) 74.00 (13.05) *** *** *** n.s. 
DSB [15] 8.68 (1.99) 4.5 (2.07) 4.52 (1.47) *** *** *** n.s. 
TMT B  A time (seconds) 39.05 (16.66) 240.42 (149.04) 121.71 (103.78) *** *** *** n.s. 
Hayling AB error score [128] 2.77 (4.92) 12.43 (6.80) 23.06 (18.66) *** *** ** n.s. 
RAVLT learning trials        
Trial 1 [15] 6.73 (2.05) 2.78 (1.56) 4.25 (1.61) *** ** *** n.s. 
Trial 2 [15] 9.91 (2.65) 3.89 (0.93) 5.75 (2.32) *** *** *** n.s. 
Trial 3 [15] 11.68 (2.40) 5.33 (2.12) 7.44 (2.68) *** *** *** n.s. 
Trial 4 [15] 12.73 (1.70) 4.89 (2.42) 7.69 (2.60) *** *** *** n.s. 
Trial 5 [15] 13.14 (1.75) 4.44 (2.19) 8.31 (3.59) *** ** *** n.s. 
RAVLT 30-minute recall [15] 10.32 (2.99) 1.56 (1.67) 4.94 (3.04) *** ** *** n.s. 
RAVLT corrected recognition [15] 12.09 (2.81)  2.44 (7.25) 2.56 (5.75) *** *** *** n.s. 
a Standard deviations in parentheses, maximum score for tests shown in brackets. 
Clinical Dementia Rating Scale (CDR); Frontotemporal Dementia Rating Scale (FRS); Addenbrooke’s Cognitive Examination (ACE-III); Digit Span 
Backwards (DSB); Trail Making Test (TMT); Rey Auditory Verbal Learning Test (RAVLT). 
*p<.05; **p<.01 ; ***p<.001 ; n.s. = non-significant; #=trend, p=.066 
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Table 2. Spearman rank correlation coefficients from analyses exploring associations between 
selectivity index scores on Trial 3 of the VDM task and performance on neuropsychological 
measures of executive function and verbal episodic memory encoding. 
 Executive function  
Verbal episodic 
memory encoding 
 
DSB  
total 
TMT  
B-A timea 
Hayling AB 
error scorea  
RAVLT  
Trial 5 total 
Controls 0.140 0.093 0.047  0.045 
AD 0.387 0.357 0.019  0.355 
bvFTD 0.382 0.416 0.560*  0.334 
aHigher scores denote greater impairment. 
Values are Spearman correlation one-tailed t tests. *p=0.01. 
